Infosys Transforms NovaSom's Sleep Apnea Diagnostic Portal to Significantly Speed Test Result Processing

 Infosys Transforms NovaSom's Sleep Apnea Diagnostic Portal to Significantly
                         Speed Test Result Processing

PR Newswire

BANGALORE, India and GLEN BURNIE, Maryland, January 14, 2013

BANGALORE, India and GLEN BURNIE, Maryland, January 14, 2013 /PRNewswire/ --

Cloud-based User Platform Expanded To Support New Offerings

Infosys, a global leader in consulting and technology, has partnered with
NovaSom, Inc., the leader in home testing for obstructive sleep apnea (OSA),
to significantly improve the efficiency of administering and analyzing results
of home tests.

Infosys has designed an innovative cloud-based user portal, Meditrack®, on
Salesforce.com to broaden the reach and efficiency of NovaSom's diagnostic
solution suite. The new portal provides physicians with a single, easy-to-use
interface that speeds up the order-to-delivery of devices, processing of
diagnostic data and management of insurance claims.

Meditrack® provides Web interfaces with third-party applications to access and
analyze patient data immediately upon wireless receipt of the completed home
sleep test. The portal, launched earlier this year, enables NovaSom to shorten
the time from test completion to report generation by two days. This
capability helps NovaSom's sleep specialist customers deliver faster diagnoses
to patients and speed their paths to treatment.

"Patients with OSA are at an increased risk of other chronic diseases. The
innovative solution that we developed for NovaSom is helping OSA patients
receive faster and better medical care, said Dheeshjith V.G., Senior Vice
President and Global Head, Life Sciences at Infosys. "Leveraging our deep
medical technology domain knowledge and harnessing the latest technical
advancementshas allowed us to enable NovaSom to facilitate rapid diagnostic
and therapy cycles."

The NovaSom diagnostic solution also leverages AccuSom®, the first and only
FDA-cleared wireless home sleep testing device. With more than 18 million
moderate to severe cases of OSA in the United States, NovaSom's suite of
accurate, cost-effective home sleep testing solutions is delivering new
benefits to patients, health insurers, and specialty and primary care
physicians.

In 2012, NovaSom expanded its product suite, launching AccuSom Deliver™, a
customized turnkey solution allowing sleep specialists to incorporate
high-quality, at-home sleep testing into their practices on a larger scale.
AccuSom Safe Recovery™ was also launched this year, which leverages AccuSom's
wireless functionality to complete home sleep testing prior to surgery. The
new portal from Infosys has helped NovaSom scale operations to meet the
expanded solution portfolio more effectively. Sleep specialists, surgeons, and
anesthesiologists can now develop a patient management plan that further
minimizes the risk of adverse respiratory events and other OSA-related
complications during and after surgery.

"A quicker OSA diagnosis is critical to helping sufferers get the therapy they
need sooner, and we are achieving that goal with the help of Infosys," said
Richard Hassett, MD, Chief Executive Officer, NovaSom. "The customized
MediTrack portal enables us to complete tests quickly and accurately.
NovaSom's cloud-based infrastructure allows us to partner with providers to
improve access to care, reduce cost and address this undiagnosed epidemic."

About NovaSom

NovaSom, Inc. is the market leader in obstructive sleep apnea home testing,
with the AccuSom Home Sleep Test, the first and only FDA-cleared wireless HST.
The NovaSomhome sleep testing technology and MediTrack portal have been shown
to provide in-home, clinically equivalent diagnosis of OSA at a significantly
reduced cost as compared to in-facility testing for uncomplicated, adult OSA.
NovaSom's home sleep tests are currently covered for more than 165 million
Americans through partnerships with major health insurers.

NovaSom also offers comprehensive service programs that are utilized by
payers, employers, primary care and sleep specialist physicians nationwide,
that enable significant cost savings for OSA management. In an effort to
combat the growing OSA epidemic, NovaSom also partners with sleep centers,
enabling sleep specialists to offer clinically appropriate patients an
alternative, convenient testing option, expanding access to diagnosis and
treatment.

NovaSom is accredited by the Joint Commission as an Ambulatory Care Sleep
Diagnostic Center & Telehealth Provider and is approved by CMS as an
Independent Diagnostic Testing Facility. For more information, visit
http://www.NovaSom.com.

About Infosys

Infosys partners with global enterprises to drive their innovation-led growth.
That's why Forbes ranked Infosys 19th among the top 100 most innovative
companies. As a leading provider of next-generation consulting, technology,
and outsourcing solutions, Infosys helps clients in more than 30 countries
realize their goals. Visit http://www.infosys.com and see how Infosys (NYSE:
INFY), with its 150,000+ people, is Building Tomorrow's Enterprise® today.

Safe Harbor

Certain statements in this release concerning our future growth prospects are
forward-looking statements, which involve a number of risks and uncertainties
that could cause actual results to differ materially from those in such
forward-looking statements. The risks and uncertainties relating to these
statements include, but are not limited to, risks and uncertainties regarding
fluctuations in earnings, fluctuations in foreign exchange rates, our ability
to manage growth, intense competition in IT services including those factors
which may affect our cost advantage, wage increases in India, our ability to
attract and retain highly skilled professionals, time and cost overruns on
fixed-price, fixed-time frame contracts, client concentration, restrictions on
immigration, industry segment concentration, our ability to manage our
international operations, reduced demand for technology in our key focus
areas, disruptions in telecommunication networks or system failures, our
ability to successfully complete and integrate potential acquisitions,
liability for damages on our service contracts, the success of the companies
in which Infosys has made strategic investments, withdrawal or expiration of
governmental fiscal incentives, political instability and regional conflicts,
legal restrictions on raising capital or acquiring companies outside India,
and unauthorized use of our intellectual property and general economic
conditions affecting our industry. Additional risks that could affect our
future operating results are more fully described in our United States
Securities and Exchange Commission filings including our Annual Report on Form
20-F for the fiscal year ended March 31, 2012 and on Form 6-K for the quarters
ended December 31, 2011, June 30, 2012 and September 30, 2012.These filings
are available at http://www.sec.gov. Infosys may, from time to time, make
additional written and oral forward-looking statements, including statements
contained in the company's filings with the Securities and Exchange Commission
and our reports to shareholders. The company does not undertake to update any
forward-looking statements that may be made from time to time by or on behalf
of the company.

For Further information please contact:

Asia Pacific
Abhijith Karthikeya D
Infosys, India
Phone: +91-80-41563373
Abhijith_Damodar@infosys.com

TheAmericas
Jay Barta
Infosys, US
Phone: +1-510-926-7840
Jay_Barta@Infosys.com

Isabel Portieles
NovaSom, Inc.  
Phone: +1-410-590-0443
iportieles@NovaSom.com

SOURCE Infosys
 
Press spacebar to pause and continue. Press esc to stop.